JP2021526375A5 - - Google Patents

Info

Publication number
JP2021526375A5
JP2021526375A5 JP2020567097A JP2020567097A JP2021526375A5 JP 2021526375 A5 JP2021526375 A5 JP 2021526375A5 JP 2020567097 A JP2020567097 A JP 2020567097A JP 2020567097 A JP2020567097 A JP 2020567097A JP 2021526375 A5 JP2021526375 A5 JP 2021526375A5
Authority
JP
Japan
Prior art keywords
colorectal
biomarker genes
subject
fecal
expression levels
Prior art date
Application number
JP2020567097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526375A (ja
JPWO2019232483A5 (https=
JP7650663B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035061 external-priority patent/WO2019232483A1/en
Publication of JP2021526375A publication Critical patent/JP2021526375A/ja
Publication of JPWO2019232483A5 publication Critical patent/JPWO2019232483A5/ja
Publication of JP2021526375A5 publication Critical patent/JP2021526375A5/ja
Application granted granted Critical
Publication of JP7650663B2 publication Critical patent/JP7650663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567097A 2018-06-01 2019-05-31 検出方法 Active JP7650663B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862679621P 2018-06-01 2018-06-01
US62/679,621 2018-06-01
US201962797763P 2019-01-28 2019-01-28
US62/797,763 2019-01-28
PCT/US2019/035061 WO2019232483A1 (en) 2018-06-01 2019-05-31 Detection method

Publications (4)

Publication Number Publication Date
JP2021526375A JP2021526375A (ja) 2021-10-07
JPWO2019232483A5 JPWO2019232483A5 (https=) 2022-06-01
JP2021526375A5 true JP2021526375A5 (https=) 2022-06-01
JP7650663B2 JP7650663B2 (ja) 2025-03-25

Family

ID=68698469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567097A Active JP7650663B2 (ja) 2018-06-01 2019-05-31 検出方法

Country Status (8)

Country Link
US (3) US20210214797A1 (https=)
EP (1) EP3802885A4 (https=)
JP (1) JP7650663B2 (https=)
CN (1) CN112567050A (https=)
AU (1) AU2019276577B2 (https=)
CA (1) CA3136405A1 (https=)
IL (1) IL279125B2 (https=)
WO (1) WO2019232483A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986412T3 (es) 2016-10-27 2024-11-11 Geneoscopy Inc Método de aislamiento de ácidos nucleicos eucariotas a partir de muestras de heces
EP4426860A4 (en) * 2021-11-01 2025-11-12 Univ Colorado State Res Found DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
KR102425034B1 (ko) * 2021-12-14 2022-07-27 주식회사 에이아이더뉴트리진 표적 바이러스 검출을 위한 페이퍼 멤브레인 기반 현장용 rna 추출 플랫폼
CN115602326A (zh) * 2022-10-21 2023-01-13 中国科学院计算技术研究所(Cn) 一种用于挖掘肿瘤标志物的方法以及肿瘤风险筛查方法
WO2024108271A1 (en) * 2022-11-25 2024-05-30 Denis King Colorectal cancer risk assessment
EP4654960A1 (en) * 2023-01-26 2025-12-03 Mayo Foundation for Medical Education and Research Assessing and treating mammals having polyps
US20260060660A1 (en) 2024-08-30 2026-03-05 Geneoscopy, Inc. Compositions and methods for immunological testing of stool

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033820B2 (ja) 2003-07-29 2008-01-16 株式会社日立製作所 細胞回収方法
JP2007175021A (ja) 2005-12-28 2007-07-12 Sysmex Corp 大腸がんのリンパ節転移マーカー
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
WO2007149269A2 (en) 2006-06-12 2007-12-27 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
GB0700374D0 (en) * 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
JPWO2008093530A1 (ja) 2007-01-30 2010-05-20 国立大学法人浜松医科大学 大腸癌病期検出方法
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
WO2009042676A1 (en) 2007-09-24 2009-04-02 University Of South Florida Method for early detection of cancers
EP2287331A4 (en) 2008-05-12 2012-01-25 Olympus Corp PROCESS FOR PROCESSING EXCREMENTS AND CONTAINERS FOR PROCESSING EXCREMENTS
CN102105583A (zh) 2008-07-23 2011-06-22 奥林巴斯株式会社 从粪便试样中回收核酸的方法、核酸分析方法以及粪便试样处理装置
WO2010042903A1 (en) 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
WO2010053539A2 (en) * 2008-11-05 2010-05-14 The Texas A&M University System Methods for detecting colorectal diseases and disorders
JPWO2010134246A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 核酸含有試料の調製方法
JPWO2010134245A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 哺乳細胞由来核酸の回収方法、核酸解析方法、及び採便用キット
EP2655661B1 (en) * 2010-12-23 2015-03-11 Agendia N.V. Methods and means for molecular classification of colorectal cancers
AU2012301589A1 (en) * 2011-08-31 2014-02-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of colorectal cancer
KR102175688B1 (ko) 2013-03-27 2020-11-06 제넨테크, 인크. 베타7 인테그린 길항제를 사용하는 위장 염증성 장애의 치료를 평가하기 위한 바이오마커의 사용
CN103324846A (zh) * 2013-06-13 2013-09-25 浙江加州国际纳米技术研究院绍兴分院 结直肠癌症治疗预后生物标记物的筛选方法
US11035006B2 (en) 2013-07-30 2021-06-15 H. Lee Moffitt Cancer Center And Research Institute, Inc. Colorectal cancer recurrence gene expression signature
US20180282815A1 (en) 2015-04-29 2018-10-04 Geneoscopy, Llc Colorectal cancer screening method and device
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
ES2986412T3 (es) * 2016-10-27 2024-11-11 Geneoscopy Inc Método de aislamiento de ácidos nucleicos eucariotas a partir de muestras de heces

Similar Documents

Publication Publication Date Title
JP2021526375A5 (https=)
Del Vecchio et al. Next-generation sequencing: recent applications to the analysis of colorectal cancer
JP5955557B2 (ja) 膵臓腫瘍形成の根底にある経路および遺伝性の膵癌遺伝子
CN110462065A (zh) 检测肿瘤复发的方法
US20140134158A1 (en) Kras mutations and resistance to anti-egfr treatment
CN106715723A (zh) 测定样品中pik3ca突变状态的方法
JP6864089B2 (ja) 進行性胃癌患者の手術後の予後または抗癌剤適合性予測システム
CN102177251A (zh) 恶性神经胶质瘤的异柠檬酸脱氢酶和其他基因的遗传改变
CN104160038B (zh) 一种用于预测对采用egfr抑制剂的治疗的响应性的方法
JP2017521058A (ja) 癌処置のための個別化三剤治療を選択するための方法
JP2021513342A (ja) 腫瘍の遺伝的不均一性を評価することによって治療法に対する応答を予測する方法
JP2011505145A5 (https=)
JP2011505145A (ja) Vegf多型および抗脈管形成治療
BR112019013391A2 (pt) Adaptador de ácido nucleico, e, método para detecção de uma mutação em uma molécula de dna circulante tumoral (ctdna) de fita dupla.
AU2010229988A1 (en) Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor
Darabi et al. Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1.
EP4578962A1 (en) Composition for amplifying flt3 gene, and uses thereof
US11434537B2 (en) Biomarker for prognosis of colorectal cancer
KR20170086469A (ko) Egfr 억제제를 사용한 치료에 대한 반응을 예측하는 방법
Leichsenring et al. Colorectal cancer: personalized therapy
CN107354197B (zh) 一种检测人类nras基因突变的试剂盒
EP4032987A1 (en) Method for predicting response to anti-cancer immunotherapy using dna methylation aberration
Lin et al. Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
KR102600344B1 (ko) Kras 유전자 돌연변이 검출용 조성물 및 이를 포함하는 키트
JPWO2019232483A5 (https=)